AvePoint, Inc. (NASDAQ:AVPT – Get Free Report) has received a consensus rating of “Moderate Buy” from the sixteen ratings firms that are covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1 year price objective among analysts […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the sixteen research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, nine have given a buy recommendation and one has […]

European Wax Center, Inc. (NASDAQ:EWCZ – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the six research firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 12-month price target […]

nLight (NASDAQ:LASR – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating, nine have given a buy rating and one has issued a strong […]

Shares of Rapid7, Inc. (NASDAQ:RPD – Get Free Report) have received an average rating of “Reduce” from the twenty-two analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, seventeen have assigned a hold recommendation and two have given a buy recommendation to the […]

Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, twelve have given a buy rating and one has given a strong buy […]

Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) has received an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the […]

TeraWulf Inc. (NASDAQ:WULF – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fourteen research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and twelve have issued a buy recommendation on the company. […]

American Public Education, Inc. (NASDAQ:APEI – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy […]

Shares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to […]

Shares of First Watch Restaurant Group, Inc. (NASDAQ:FWRG – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, ten have issued a buy rating […]

Galapagos NV (NASDAQ:GLPG – Get Free Report) has been assigned an average rating of “Hold” from the seven brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company. […]

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, thirteen have issued a buy rating and one has issued a strong buy […]